In situ hybridization studies on brain tissue have shown that the excitatory amino acid transporter 2 (EAAT2) mRNA labeling decreases, and it correlates with HD severity and progression (Arzberger et al., 1997). This evidence concerns the gene SLC1A2 and Huntington disease.